Delivery of Cancer Therapeutics | AIChE

Other Sites & Tools

Technical Groups

Delivery of Cancer Therapeutics

Co-chair(s)

Bao, X., Purdue University
Zhang, F., Fred Hutchinson Cancer Research Institute

This session highlights recent advances in methods and related technologies for delivery of therapeutics for cancer. This includes novel drug carriers, material design, and cell-based platforms.

Presentations

8:00 AM
(15a) Synergy of an HDAC Inhibitor and Chemotherapy Delivered Via Lipid Nanoemulsions for TNBC
8:15 AM
(15b) Mesenchymal Stem Cells Anchored with Thymidine Phosphorylase for Doxifluridine-Mediated Cancer Therapy
8:30 AM
(15c) Calcium Phosphate-Polymeric Nanoparticle System for Co-delivery ofmicroRNA-21 Inhibitor and Doxorubicin
8:45 AM
(15e) Antibody Drug Nanoparticle Induces Synergistic Treatment Efficacies in Breast Cancer Cells
9:00 AM
(15f) ICAM-1 Nanobody Density on Liposomes Affects Selectivity for Triple Negative Breast Cancer and Inflamed Endothelium
9:15 AM
(15g) Peptide Engineering for Targeted, Intracellular Delivery of siRNA and Proteins (INVITED SPEAKER)

Topics 

Biomedical Engineering

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00

More Conference Links